Brazikumab (anti-IL-23) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab (anti-IL-23) can be used for the research of Crohn's disease.
Specifications and Purity: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
- UPC:
- 42202105
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab175478-5mg
- CAS:
- 1610353-18-8
- Product Size:
- 5mg
akash.verma@cenmed.com
(732) 447-1115





